Vicebio Revenue and Competitors

USA

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Vicebio has 20 Employees.(i)
  • Vicebio grew their employee count by 100% last year.

Vicebio's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$10.1M48-9%N/AN/A
#10
$16.1M884%N/AN/A
Add Company

What Is Vicebio?

Vicebio is a clinical-stage biopharmaceutical company developing transformative multi-pathogen vaccines for respiratory viral infections.\nAt the core of our work is Vicebio’s groundbreaking Molecular Clamp Technology, which locks viral proteins in their optimal conformation. This innovation enables our vaccines to deliver a unique combination of broad protection, ready-to-use administration, and convenient manufacturing.\nOur lead program is a best-in-class multivalent vaccine targeting five respiratory diseases, positioning Vicebio as a leader in multipathogen respiratory vaccines.

keywords:N/A

N/A

Total Funding

20

Number of Employees

N/A

Revenue (est)

100%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.7M20-5%N/A
#2
$4.1M20-13%N/A
#3
$3.6M20-33%N/A
#4
$2M20N/AN/A
#5
$2M20N/AN/A